Summary

The Europe brain implants market was valued at US$ 2,133.30 million in 2022 and is expected to reach US$ 5,162.17 million by 2030; it is estimated to grow at a CAGR of 11.7% from 2022 to 20 30.

Rising Number of Spinal Cord Injuries Fuels the Europe Brain Implants Market

As per the Spinal Injuries Association, ~2,500 people sustain an SCI annually in the UK, and ~50,000 persons are living with an SCI in the country. SCI can lead to severe locomotor deficits or even complete leg paralysis. Spinal cord stimulation is one of the most preferred techniques employed to treat such situations. According to the article "Epidemiology of traumatic spinal cord injuries: a large population-based study," published in April 2022, the overall age–sex-standardized incidence rate of traumatic spinal cord injuries was 26.5 per 1 million population, and the rates were directly related to age in both the genders. Moreover, the incidence rate of traumatic spinal cord injuries is 59.2 per 1 million and 23.3 per 1 million in males and females, respectively, in people aged 65 and above. Spinal cord stimulators are implantable devices that help block pain signals sent from the brain. Therefore, increasing cases of spinal cord injuries fuel the demand for spinal cord stimulators, which in turn drives the growth of the brain implants market.

Europe Brain Implants Market Overview

The European brain implants market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The factors driving the market growth include Key factors driving the market growth are surging prevalence of neurological disorders with increasing geriatric population and rising number of spinal cords injuries. However, high cost associated with brain implant devices and procedures hinders the market growth. According to a study published at Charité—Universitätsmedizin Berlin, titled "Deep brain stimulation for Parkinson's disease: new algorithm for the adjustment of stimulation settings developed," published in 2022, Parkinson's disease (PD) is the second most common neurodegenerative disease after Alzheimer's. ~400,000 people were affected by the disease in Germany, and the numbers are increasing due to demographic aging. A growing number of people, including younger people, suffer from neurodegenerative diseases. As per DZNE, German Center for Neurodegenerative Diseases, over 2 million people have dementia or PD in the country. Brain implants have emerged as a potential treatment for PD. These implants, also known as deep brain stimulation (DBS), involve the surgical placement of electrodes in specific areas of the brain.

Europe Brain Implants Market Revenue and Forecast to 2030 (US$ Million)

Europe Brain Implants Market Segmentation

The Europe brain implants market is segmented into treatment, application, end user, and country.

Based on treatment, the Europe brain implants market is classified into deep brain stimulation, spinal cord stimulation, vagus nerve stimulator, invasive and non-invasive brain–computer interface, responsive neurostimulation for seizures, auditory brainstem implant, and ophthalmic aid/implant. The spinal cord stimulation segment held the largest share in 2022. Further, the auditory brainstem implant segment is bifurcated into retrocochlear hearing impairment and cochlear hearing impairment.

In terms of application, the Europe brain implants market is categorized into chronic pain, Parkinson’s disease, Alzheimer’s disease, epilepsy, essential tremor, depression, dystonia, amyotrophic lateral sclerosis (ALS), and neurofibromatosis 2. The chronic pain segment held the largest share in 2022.

Based on end user, the Europe brain implants market is bifurcated into hospitals and specialized clinics/neurological centers. The hospitals segment held the largest share in 2022.

Based on country, the Europe brain implants market is segmented the UK, Germany, France, Spain, Italy, and the Rest of Europe. Germany dominated the Europe brain implants market in 2022.

Abbott Laboratories, Aleva Neurotherapeutics SA, Boston Scientific Corp, Medtronic Plc, NeuroSky Inc, ONWARD Medical NV, and Renishaw Plc are some of the leading companies operating in the Europe brain implants market.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Brain Implants Market Landscape
4.1 Overview
5. Europe Brain Implants Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Surging Prevalence of Neurological Disorders with Increasing Geriatric Population
5.1.2 Rising Number of Spinal Cord Injuries
5.2 Key Market Restraints
5.2.1 High Cost Associated with Brain Implant Devices and Procedures
5.3 Key Market Opportunities
5.3.1 Strategic Initiatives by Companies
5.4 Key Future Trends
5.4.1 Technological Advancements such as Miniaturization, Artificial Intelligence, and Modern Brain-Machine Interfaces
5.5 Impact Analysis:
6. Brain Implants Market - Europe Market Analysis
6.1 Overview
6.2 Europe Brain Implants Market Revenue (US$ Mn), 2022 - 2030
7. Europe Brain Implants Market - Revenue and Forecast to 2030 - by Treatment.
7.1 Overview
7.2 Europe Brain Implants Market Revenue Share, by Treatment, 2022 & 2030 (%)
7.3 Deep Brain Stimulation
7.3.1 Overview
7.3.2 Deep Brain Stimulation: Europe Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Spinal Cord Stimulation
7.4.1 Overview
7.4.2 Spinal Cord Stimulation: Europe Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Vagus Nerve Stimulator
7.5.1 Overview
7.5.2 Vagus Nerve Stimulator: Europe Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Invasive and Non-Invasive Brain-Computer Interfaces
7.6.1 Overview
7.6.2 Invasive and Non-Invasive Brain-Computer Interfaces: Europe Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Responsive Neurostimulation for Seizures
7.7.1 Overview
7.7.2 Responsive Neurostimulation for Seizures: Europe Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Auditory Brainstem Implant
7.8.1 Overview
7.8.2 Auditory Brainstem Implant: Europe Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
7.8.2.1 Retrocochlear Hearing Impairment
7.8.2.1.1 Retrocochlear Hearing Impairment: Auditory Brainstem Implants Market- Revenue and Forecast to 2030 (US$ Million)
7.8.2.2 Cochlear Hearing Impairment
7.8.2.2.1 Cochlear Hearing Impairment: Auditory Brainstem Implants Market- Revenue and Forecast to 2030 (US$ Million)
7.9 Ophthalmic Aids/Implant
7.9.1 Overview
7.9.2 Ophthalmic Aids/Implant: Europe Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
8. Europe Brain Implants Market - Revenue and Forecast to 2030 - by Application
8.1 Overview
8.2 Europe Brain Implants Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Chronic Pain
8.3.1 Overview
8.3.2 Chronic Pain: Europe Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Parkinson's disease
8.4.1 Overview
8.4.2 Parkinson's disease: Europe Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Alzheimer's disease
8.5.1 Overview
8.5.2 Alzheimer's disease: Europe Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Epilepsy
8.6.1 Overview
8.6.2 Epilepsy: Europe Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Essential Tremor
8.7.1 Overview
8.7.2 Essential Tremor: Europe Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
8.8 Depression
8.8.1 Overview
8.8.2 Depression: Europe Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
8.9 Dystonia
8.9.1 Overview
8.9.2 Dystonia: Europe Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
8.10 Amyotrophic Lateral Sclerosis
8.10.1 Overview
8.10.2 Amyotrophic Lateral Sclerosis (ALS): Europe Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
8.11 Neurofibromatosis 2
8.11.1 Overview
8.11.2 Neurofibromatosis 2: Europe Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
9. Europe Brain Implants Market - Revenue and Forecast to 2030 - by End User
9.1 Overview
9.2 Europe Brain Implants Market Revenue Share, by End-User, 2022 & 2030 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Europe Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Specialized Clinics / Neurological Centers
9.4.1 Overview
9.4.2 Specialized Clinics / Neurological Centers: Europe Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
10. Europe Brain Implants Market - Country Analysis
10.1 Europe Brain Implants Market, by Key Country- Revenue, (2022) (US$ Million)
10.1.1 Europe Brain Implants Market, by Country
10.1.1.1 UK
10.1.1.1.1 UK: Europe Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.1.2 UK: Europe Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
10.1.1.1.2.1 UK: Europe Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
10.1.1.1.3 UK: Europe Brain Implants Market, by Application, 2020-2030 (US$ Million)
10.1.1.1.4 UK: Europe Brain Implants Market, by End-User, 2020-2030 (US$ Million)
10.1.1.2 Germany
10.1.1.2.1 Germany: Europe Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.2.2 Germany: Europe Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
10.1.1.2.2.1 Germany: Europe Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
10.1.1.2.3 Germany: Europe Brain Implants Market, by Application, 2020-2030 (US$ Million)
10.1.1.2.4 Germany: Europe Brain Implants Market, by End-User, 2020-2030 (US$ Million)
10.1.1.3 France
10.1.1.3.1 France: Europe Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.3.2 France: Europe Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
10.1.1.3.2.1 France: Europe Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
10.1.1.3.3 France: Europe Brain Implants Market, by Application, 2020-2030 (US$ Million)
10.1.1.3.4 France: Europe Brain Implants Market, by End-User, 2020-2030 (US$ Million)
10.1.1.4 Italy
10.1.1.4.1 Italy: Europe Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.4.2 Italy: Europe Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
10.1.1.4.2.1 Italy: Europe Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
10.1.1.4.3 Italy: Europe Brain Implants Market, by Application, 2020-2030 (US$ Million)
10.1.1.4.4 Italy: Europe Brain Implants Market, by End-User, 2020-2030 (US$ Million)
10.1.1.5 Spain
10.1.1.5.1 Spain: Europe Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.5.2 Spain: Europe Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
10.1.1.5.2.1 Spain: Europe Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
10.1.1.5.3 Spain: Europe Brain Implants Market, by Application, 2020-2030 (US$ Million)
10.1.1.5.4 Spain: Europe Brain Implants Market, by End-User, 2020-2030 (US$ Million)
10.1.1.6 Rest of Europe
10.1.1.6.1 Rest of Europe Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.6.2 Rest of Europe: Europe Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
10.1.1.6.2.1 Rest of Europe: Europe Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
10.1.1.6.3 Rest of Europe: Europe Brain Implants Market, by Application, 2020-2030 (US$ Million)
10.1.1.6.4 Rest of Europe: Europe Brain Implants Market, by End-User, 2020-2030 (US$ Million)
11. Europe Brain Implants Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in Europe Brain Implants Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Boston Scientific Corp
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Medtronic Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Renishaw Plc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Abbott Laboratories
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 CorTec GmbH
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 SWOT Analysis
12.5.5 Key Developments
12.6 Aleva Neurotherapeutics SA
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 SWOT Analysis
12.6.5 Key Developments
12.7 NeuroSky Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 SWOT Analysis
12.7.5 Key Developments
12.8 ONWARD Medical NV
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms